Also trades as: SOM.AX (ASX) · $vol 0M
SOMNF OTC
SomnoMed Limited
1W: +0.0%
1M: -46.7%
3M: -46.7%
YTD: -52.9%
1Y: -45.5%
3Y: -45.5%
5Y: -86.0%
$0.24
-0.00 (-0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$114M
+2.6% ▲
5Y CAGR: +12.8%
Gross Profit
$61M
-8.8% ▼
5Y CAGR: +12.4%
Operating Income
$975K
-73.1% ▼
Net Income
-$3M
+23.4% ▲
EPS (Diluted)
$-0.01
+25.8% ▲
EBITDA
$6M
+307.5% ▲
5Y CAGR: +59.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $73M | $84M | $92M | $111M | $114M |
| YoY Growth | +15.7% | +15.2% | +9.6% | +21.6% | +2.6% |
| Cost of Revenue | $33M | $38M | $37M | $45M | $54M |
| Gross Profit | $39M | $46M | $55M | $67M | $61M |
| Gross Margin | 53.9% | 54.7% | 60.2% | 59.9% | 53.2% |
| R&D Expenses | $1M | $881K | $1M | $2M | $2M |
| SG&A Expenses | $34M | $39M | $44M | $61M | $58M |
| Operating Expenses | $43M | $50M | $63M | $63M | $60M |
| Operating Income | -$4M | -$4M | -$8M | $4M | $975K |
| Operating Margin | -5.7% | -4.9% | -9.1% | 3.2% | 0.9% |
| Interest Expense | $380K | $3M | $3M | $381K | $463K |
| Income Before Tax | -$3M | -$7M | -$11M | -$764K | -$457K |
| Tax Expense | $931K | $822K | $971K | $3M | $2M |
| Net Income | -$4M | -$8M | -$12M | -$3M | -$3M |
| Net Margin | -6.1% | -9.6% | -13.4% | -3.1% | -2.3% |
| EPS (Diluted) | $-0.05 | $-0.10 | $-0.10 | $-0.02 | $-0.01 |
| EBITDA | -$2M | -$3M | -$2M | $2M | $6M |
| Shares Outstanding | 82M | 82M | 121M | 212M | 216M |